Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: A study with monotherapy of 50/50 premixed insulin analogue three times daily injection

Journal of Diabetes and its Complications

Volumn 25, Issue 2, 2011, Pages 83-89

  Tanaka, Masami ^a   Ishii, Hitoshi ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

50 50 premixed rapid acting insulin analogue; Bedtime plasma glucose; Blood glucose control; Hypoglycemia; Insulin therapy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

AGED; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROGNOSIS; TIME FACTORS;

EID: 79952316761     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2010.05.001     Document Type: Article

References (13)

1. Boden G., Chen X., and Urbain J.L Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production Diabetes 45 1996 1044 1050 (Pubitemid 26260156)
2. Cavalot F., Petrelli A., Traversa M., Bonomo K., Fiora E., Conti M., Anfossi G., Costa G., and Trovati M. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in Type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study Journal of Clinical Endocrinology and Metabolism 91 2006 813 819 (Pubitemid 43357744)
3. Esposito K., Ciotola M., Maiorino M.I., Gualdiero R., Schisano B., Ceriello A., Beneduce F., Feola G., and Giugliano D. Addition of neutral protamine lispro or insulin glargine to oral Type 2 diabetes regimens for patients with suboptimal glycemic control. A randomized trial Annals of Internal Medicine 149 2008 531 539
4. Hanefeld M., Cagatay M., Petrowitsch T., Neuser D., Petzinna D., and Rupp M. Acarbose reduces the risk for myocardial infraction in Type 2 diabetic patients: meta-analysis of seven long-term studies European Heart Journal 25 2004 10 16 (Pubitemid 38055587)
5. Ishii H., Anderson J.H. Jr, Yamamura A., Takeuchi M., and Ikeda I. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires Diabetes Research and Clinical Practice 81 2008 169 178
6. Ishii H., Furuya M., Iburi T., Yamagami K., Ishibashi E., and Tsujii S. Quality of life in insulin-treated patients Journal of Japan Diabetes Society 51 2008 601 608 (in Japanese)
7. Kazda C., Hülstrunk H., Helsberg K., Langer F., Forst T., and Hanefeld M. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trials in patients with Type 2 diabetes beginning insulin therapy Journal of Diabetes and its Complications 20 2006 145 152 (Pubitemid 44316603)
8. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of Type 2 diabetic patients Diabetes Care 26 2003 881 885 (Pubitemid 36929359)
9. Polonsky B.D., Given E., and Cauter E.V. Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects Journal of Clinical Investigation 81 1988 442 448
10. Robibins D.C., Beisswenger P.J., Ceriello A., Goldberg R.B., Moses R.G., Pagkalos E.M., Milicevic Z., Jones C.A., Sarwat S., and Tan M.H. Mealtime 50/50 basal+prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels on patients with Type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison Clinical Therapeutics 29 2007 2349 2364
11. Rosenstock J., Ahmann A.J., Colon G., Scism-Bacon J., Jiang H., and Martin S. Advancing insulin therapy in Type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy Diabetes Care 31 2008 20 25
12. Rosenstock J., Davies M., Home P.D., Larsen J., Koenen C., and Schernthaner G. A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with Type 2 diabetes Diabetologia 51 2008 408 416
13. Yokoyama H., Tada J., Kamikawa F., Kanno S., Yokota Y., and Kuramitsu M. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in Type 2 diabetic patients on basal-prandial insulin therapy Diabetes Research and Clinical Practice 73 2006 35 40 (Pubitemid 44226296)